The number of shares of the Company’s common stock to be issued pursuant to the Series A Conversion Proposal, PMX Issuance Proposal, and Warrant Inducement Proposal shall be adjusted to reflect the ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” said Jeffrey ...
Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...
The completion of the Proposed Transaction is subject to the fulfilment, or waiver, of certain conditions, including board approvals, regulatory approvals, a satisfactory due diligence process, and ...
Recent testing from Consumer Reports and the FDA has found elevated levels of lead in cinnamon products and spice mixes. You ...
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
The agency reviewed data from the MARIPOSA-2 trial and approved the regimen for patients with common EGFR mutations who are progressing on EGFR inhibitors.
Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).
On to Plan B. House Republican leaders were unable to win passage Wednesday night of a stopgap spending bill that would have ...
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback